Active, not recruitingPhase 3NCT05537220

Oral N-acetylcysteine for Retinitis Pigmentosa

Studying Retinitis pigmentosa

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Johns Hopkins University
Principal Investigator
Peter A Campochiaro, MD
Johns Hopkins University
Intervention
N-acetylcysteine(drug)
Enrollment
485 enrolled
Eligibility
18-65 years · All sexes
Timeline
20232030

Study locations (30)

Collaborators

National Eye Institute (NEI) · Duke University · Emory University · Massachusetts Eye and Ear Infirmary · Mayo Clinic · Medical College of Wisconsin · Retina Foundation of the Southwest · Stanford University · University of California, Davis · University of Florida · University of Iowa · University of Miami · University of Michigan · University of Minnesota · University of Oklahoma · University of Southern California · University of Utah · University of Washington · University of Wisconsin, Madison · Vanderbilt University · Vitreo Retinal Associates, PA · University of Houston · Medical University of Graz · McGill University · Universität Tübingen · Radboud University Medical Center · University of Amsterdam · University Hospital, Basel, Switzerland · University College London Hospitals · Northwestern University · University of Pennsylvania

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05537220 on ClinicalTrials.gov

Other trials for Retinitis pigmentosa

Additional recruiting or active studies for the same condition.

See all trials for Retinitis pigmentosa

← Back to all trials